ArticleVirologica Sinica2025
African swine fever virus MGF360-9L degrades DDX20 through the Rab1A-dependent autophagy pathway to antagonize its antiviral effect.
Article in Virologica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
African swine fever (ASF) is an acute, hemorrhagic, and highly contagious disease in pigs caused by the African swine fever virus (ASFV). Our previous studies have demonstrated that deletion of the MGF360-9L gene weakens ASFV virulence in pigs, yet the underlying mechanism remains unclear. To investigate the mechanism of MGF360-9L regulating ASFV pathogenicity, the relationship between MGF360-9L and host proteins was identified by mass spectrometry. We found that host protein DEAD-box helicase 20 (DDX20) interacted with and colocalized with MGF360-9L. Overexpression of DDX20 inhibited ASFV replication, whereas knockdown of DDX20 had the opposite effects. Moreover, DDX20 inhibited ASFV replication by promoting the activation of type I interferon signaling. Surprisingly, DDX20 was gradually degraded following ASFV infection. Mechanistically, MGF360-9L promoted the autophagic degradation of DDX20 by recruiting autophagy-related protein Ras-related protein Rab-1A (Rab1A). Silencing Rab1A suppressed ASFV replication, while overexpression of Rab1A exhibited the opposite effects. Furthermore, Rab1A, MGF360-9L and DDX20 could form a complex to facilitate the degradation of DDX20. Knockdown of Rab1A impaired MGF360-9L-mediated degradation of DDX20 during ASFV infection. In summary, our study demonstrates that MGF360-9L targets DDX20 for autophagy degradation to antagonize its antiviral function and facilitate ASFV replication. This finding broadens our understanding of the regulatory network between ASFV and its host, and provides new insights into the pathogenesis and immune evasion mechanisms of ASFV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.